Search
for
Sort by
Research 61–90 of 1000+
- Implication of Human Bacterial Gut Microbiota on Immune-Mediated and Autoimmune Dermatological Diseases and Their Comorbidities: A Narrative Review
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Keratins 6, 16, and 17 in Health and Disease: A Summary of Recent Findings
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study
- Vitamin D and the Skin: An Update for Dermatologists
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Medicinal Plants for Skin Health: A Holistic Review of Botanical Interventions
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- Skin Microbiome Shifts in Various Dermatological Conditions
- Blue Light in Dermatology
- Abstracts from the 2025 WDS Forum
- The JAK/STAT signaling pathway: from bench to clinic
- Cutaneous reactions to recombinant cytokine therapy
- Transdermal Liposomal Delivery Systems: Advantages, Applications, Challenges, and Prospects
- Lymphomatoid granulomatosis
- The Rotterdam Study: 2016 objectives and design update
- Assessing the Environmental and Health Adverse Effects of Mercury Released From Dental Amalgam: A Literature Review
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- 1,314
- Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Anxiety in the Medically Ill: A Systematic Review of the Literature
- The Multiple Consequences of Obesity
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Investigation of the Clinical Efficacy of Quercetin in Feline Atopic Dermatitis Syndrome
- Mechanism of Sleep Disturbance in Children with Atopic Dermatitis and the Role of the Circadian Rhythm and Melatonin
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo